Option Care Health, Inc. (NASDAQ:OPCH) Receives Average Rating of “Moderate Buy” from Brokerages

Shares of Option Care Health, Inc. (NASDAQ:OPCH) have been assigned an average recommendation of “Moderate Buy” from the eleven brokerages that are presently covering the firm, MarketBeat reports. Two analysts have rated the stock with a hold recommendation, eight have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $37.2727.

A number of research firms have issued reports on OPCH. Stephens raised shares of Option Care Health to a “strong-buy” rating in a research note on Thursday, December 11th. Citizens Jmp reaffirmed a “market outperform” rating and set a $38.00 price target (up from $36.00) on shares of Option Care Health in a report on Tuesday, January 13th. Jefferies Financial Group reiterated a “buy” rating and set a $37.00 price objective on shares of Option Care Health in a research report on Tuesday, January 13th. Morgan Stanley increased their price objective on Option Care Health from $35.00 to $38.00 and gave the stock an “overweight” rating in a report on Tuesday, January 13th. Finally, Bank of America raised their target price on Option Care Health from $32.00 to $35.00 and gave the company a “buy” rating in a research report on Tuesday, December 9th.

Option Care Health Stock Performance

Shares of OPCH opened at $29.66 on Thursday. Option Care Health has a 1 year low of $24.24 and a 1 year high of $36.80. The company has a market cap of $4.64 billion, a price-to-earnings ratio of 23.17, a price-to-earnings-growth ratio of 1.66 and a beta of 0.85. The company has a debt-to-equity ratio of 0.87, a quick ratio of 0.96 and a current ratio of 1.53. The firm has a fifty day moving average of $33.41 and a 200-day moving average of $30.75.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings results on Tuesday, February 24th. The company reported $0.46 EPS for the quarter, hitting the consensus estimate of $0.46. Option Care Health had a net margin of 3.67% and a return on equity of 18.57%. The business had revenue of $1.47 billion during the quarter, compared to analyst estimates of $1.46 billion. During the same quarter in the prior year, the firm earned $0.44 earnings per share. The company’s quarterly revenue was up 8.8% on a year-over-year basis. As a group, equities analysts anticipate that Option Care Health will post 1.22 earnings per share for the current year.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. V Square Quantitative Management LLC bought a new stake in shares of Option Care Health during the fourth quarter valued at about $25,000. Cornerstone Planning Group LLC grew its position in Option Care Health by 7,621.4% in the 3rd quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock valued at $30,000 after buying an additional 1,067 shares in the last quarter. Advisory Services Network LLC bought a new position in Option Care Health in the 3rd quarter valued at about $35,000. McIlrath & Eck LLC acquired a new position in Option Care Health during the 2nd quarter valued at about $37,000. Finally, Caitong International Asset Management Co. Ltd acquired a new position in Option Care Health during the 3rd quarter valued at about $38,000. 98.05% of the stock is owned by institutional investors and hedge funds.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.